ME1DB Stock Overview
Engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Melodiol Global Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.005 |
| 52 Week High | AU$0.005 |
| 52 Week Low | AU$0.002 |
| Beta | 2.66 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| ME1DB | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | 1.8% |
| 1Y | n/a | 56.8% | 10.8% |
Return vs Industry: Insufficient data to determine how ME1DB performed against the Australian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ME1DB performed against the Australian Market.
Price Volatility
| ME1DB volatility | |
|---|---|
| ME1DB Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 16.3% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: ME1DB's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ME1DB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Will Lay | melodiolglobalhealth.com |
Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser.
Melodiol Global Health Limited Fundamentals Summary
| ME1DB fundamental statistics | |
|---|---|
| Market cap | AU$3.42m |
| Earnings (TTM) | -AU$53.94m |
| Revenue (TTM) | AU$11.68m |
0.3x
P/S Ratio-0.1x
P/E RatioIs ME1DB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ME1DB income statement (TTM) | |
|---|---|
| Revenue | AU$11.68m |
| Cost of Revenue | AU$14.02m |
| Gross Profit | -AU$2.34m |
| Other Expenses | AU$51.61m |
| Earnings | -AU$53.94m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | -20.00% |
| Net Profit Margin | -461.80% |
| Debt/Equity Ratio | 115.9% |
How did ME1DB perform over the long term?
See historical performance and comparison